Cost-utility of ranibizumab versus aflibercept for treating...

Cost Effectiveness and Resource Allocation 2016 / 12 Vol. 14; Iss. 1

Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema

Kourlaba, Georgia, Relakis, John, Mahon, Ronan, Kalogeropoulou, Maria, Pantelopoulou, Georgia, Kousidou, Olga, Maniadakis, Nikos
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Cost Effectiveness and Resource Allocation
DOI:
10.1186/s12962-016-0056-1
Date:
December, 2016
File:
PDF, 1018 KB
english, 2016
Conversion to is in progress
Conversion to is failed